Back
Standard Chartered PLC Vs. Agios Pharmaceuticals Industry Stock Comparison
Buy
61
SCBFF
Standard Chartered PLC
Last Price:
12.87
Seasonality Move:
3.42%
Sell
2
AGIO
Agios Pharmaceuticals
Last Price:
38.94
Seasonality Move:
20.75%
Buy
61
Standard Chartered PLC (SCBFF)
is a Buy
Is Standard Chartered PLC a Buy, Sell or Hold?
- The current Standard Chartered PLC [SCBFF] share price is $12.87. The Score for SCBFF is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- SCBFF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
2
Agios Pharmaceuticals (AGIO)
is a Sell
Is Agios Pharmaceuticals a Buy, Sell or Hold?
- The current Agios Pharmaceuticals [AGIO] share price is $38.97. The Score for AGIO is 2, which is 96% below its historic median score of 50, and infers higher risk than normal.
- AGIO is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
SCBFF Stock Price Chart
What is Standard Chartered PLC's stock price today?
-
The Standard Chartered PLC share price today is $12.87
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SCBFF is experiencing buying pressure, which is a positive indicator for future bullish movement.
AGIO Stock Price Chart
What is Agios Pharmaceuticals's stock price today?
-
The Agios Pharmaceuticals share price today is $38.97
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AGIO is experiencing buying pressure, which is a positive indicator for future bullish movement.
SCBFF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.35 | Buy |
| Relative Strength Index (14 RSI): | 68.79 | Buy |
| Chaikin Money Flow: | 28339 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.79 - 12.57) | Buy |
| Bollinger Bands (100): | (9.46 - 11.78) | Buy |
AGIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.2 | Sell |
| Relative Strength Index (14 RSI): | 28.25 | Sell |
| Chaikin Money Flow: | 740295 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (48.22 - 61.14) | Sell |
| Bollinger Bands (100): | (41.85 - 53.15) | Sell |
SCBFF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.63 | Buy |
| 20-day SMA: | 12.22 | Buy |
| 50-day SMA: | 11.58 | Buy |
| 200-day SMA: | 9.78 | Buy |
| 8-day EMA: | 12.63 | Buy |
| 20-day EMA: | 12.31 | Buy |
| 50-day EMA: | 11.66 | Buy |
| 200-day EMA: | 10.11 | Buy |
AGIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.4 | Sell |
| 20-day SMA: | 53.73 | Sell |
| 50-day SMA: | 49.6 | Sell |
| 200-day SMA: | 41.93 | Sell |
| 8-day EMA: | 46.69 | Sell |
| 20-day EMA: | 51.08 | Sell |
| 50-day EMA: | 50.45 | Sell |
| 200-day EMA: | 42.79 | Sell |
Standard Chartered PLC Earnings Growth & SCBFF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Agios Pharmaceuticals Earnings Growth & AGIO Earnings Dates
- Analysts estimate an earnings increase this quarter of $9.62 per share, a decrease next quarter of $0.00 per share, an increase this year of $17.46 per share, and a decrease next year of $16.90 per share.
Standard Chartered PLC Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Agios Pharmaceuticals Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||